These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans. Wreven E; Ruiz de Adana MS; Hardivillé S; Gmyr V; Kerr-Conte J; Chetboun M; Pasquetti G; Delalleau N; Thévenet J; Coddeville A; Vallejo Herrera MJ; Hinden L; Benavides Espínola IC; Gómez Duro M; Sanchez Salido L; Linares F; Bermúdez-Silva FJ; Tam J; Bonner C; Egan JM; Olveira G; Colomo N; Pattou F; González-Mariscal I Diabetologia; 2024 Sep; 67(9):1877-1896. PubMed ID: 38864887 [TBL] [Abstract][Full Text] [Related]
3. A novel subpopulation of monocytes with a strong interferon signature indicated by SIGLEC-1 is present in patients with in recent-onset type 1 diabetes. Guo M; Guo H; Zhu J; Wang F; Chen J; Wan C; Deng Y; Wang F; Xu L; Chen Y; Li R; Liu S; Zhang L; Wang Y; Zhou J; Li S Diabetologia; 2024 Apr; 67(4):623-640. PubMed ID: 38349399 [TBL] [Abstract][Full Text] [Related]
5. Restoration of the type I IFN-IL-1 balance through targeted blockade of PTGER4 inhibits autoimmunity in NOD mice. Rahman MJ; Rodrigues KB; Quiel JA; Liu Y; Bhargava V; Zhao Y; Hotta-Iwamura C; Shih HY; Lau-Kilby AW; Malloy AM; Thoner TW; Tarbell KV JCI Insight; 2018 Feb; 3(3):. PubMed ID: 29415894 [TBL] [Abstract][Full Text] [Related]
6. Innate immune activity as a predictor of persistent insulin secretion and association with responsiveness to CTLA4-Ig treatment in recent-onset type 1 diabetes. Cabrera SM; Engle S; Kaldunski M; Jia S; Geoffrey R; Simpson P; Szabo A; Speake C; Greenbaum CJ; ; Chen YG; Hessner MJ Diabetologia; 2018 Nov; 61(11):2356-2370. PubMed ID: 30167736 [TBL] [Abstract][Full Text] [Related]
7. Heightened interferon-alpha/beta response causes myeloid cell dysfunction and promotes T1D pathogenesis in NOD mice. Peng RH; Paek E; Xia CQ; Tennyson N; Clare-Salzler MJ Ann N Y Acad Sci; 2006 Oct; 1079():99-102. PubMed ID: 17130537 [TBL] [Abstract][Full Text] [Related]
8. Increased nonobese diabetic Th1:Th2 (IFN-gamma:IL-4) ratio is CD4+ T cell intrinsic and independent of APC genetic background. Koarada S; Wu Y; Olshansky G; Ridgway WM J Immunol; 2002 Dec; 169(11):6580-7. PubMed ID: 12444170 [TBL] [Abstract][Full Text] [Related]
9. Disease resistant, NOD-related strains reveal checkpoints of immunoregulation in the pancreas. Rothe H; Ito Y; Kolb H J Mol Med (Berl); 2001 May; 79(4):190-7. PubMed ID: 11409710 [TBL] [Abstract][Full Text] [Related]
10. Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS- expressing cells and relationships to cytokines expressed in the islets. Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC Endocrinology; 1996 May; 137(5):2093-9. PubMed ID: 8612552 [TBL] [Abstract][Full Text] [Related]
11. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC; Power RF J Immunol; 1995 May; 154(9):4874-82. PubMed ID: 7722337 [TBL] [Abstract][Full Text] [Related]
12. IFNɣ but not IFNα increases recognition of insulin defective ribosomal product-derived antigen to amplify islet autoimmunity. Thomaidou S; Munoz Garcia A; de Lange S; Gan J; van der Slik AR; Hoeben RC; Roep BO; Carlotti F; Zaldumbide A Diabetologia; 2023 Nov; 66(11):2075-2086. PubMed ID: 37581620 [TBL] [Abstract][Full Text] [Related]
14. Investigation of coordination and order in transcription regulation of innate and adaptive immunity genes in type 1 diabetes. Gao S; Wolanyk N; Chen Y; Jia S; Hessner MJ; Wang X BMC Med Genomics; 2017 Jan; 10(1):7. PubMed ID: 28143555 [TBL] [Abstract][Full Text] [Related]
16. CD8 T cells in innate immune responses: using STAT4-dependent but antigen-independent pathways to gamma interferon during viral infection. Suarez-Ramirez JE; Tarrio ML; Kim K; Demers DA; Biron CA mBio; 2014 Oct; 5(5):e01978-14. PubMed ID: 25336459 [TBL] [Abstract][Full Text] [Related]
17. Understanding the increased risk of infections in diabetes: innate and adaptive immune responses in type 1 diabetes. Janssen AWM; Stienstra R; Jaeger M; van Gool AJ; Joosten LAB; Netea MG; Riksen NP; Tack CJ Metabolism; 2021 Aug; 121():154795. PubMed ID: 33971203 [TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8. Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392 [TBL] [Abstract][Full Text] [Related]
19. MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression. Shaler CR; Choi J; Rudak PT; Memarnejadian A; Szabo PA; Tun-Abraham ME; Rossjohn J; Corbett AJ; McCluskey J; McCormick JK; Lantz O; Hernandez-Alejandro R; Haeryfar SMM PLoS Biol; 2017 Jun; 15(6):e2001930. PubMed ID: 28632753 [TBL] [Abstract][Full Text] [Related]
20. Knockout of vascular smooth muscle EGF receptor in a mouse model prevents obesity-induced vascular dysfunction and renal damage in vivo. Stern C; Schreier B; Nolze A; Rabe S; Mildenberger S; Gekle M Diabetologia; 2020 Oct; 63(10):2218-2234. PubMed ID: 32548701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]